Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-552-8 | CAS number: 2809-21-4
Health surveillance data
Administrative data
- Endpoint:
- health surveillance data
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- No data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Only a summary report was available for review.
Data source
Reference
- Reference Type:
- secondary source
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
- Study type:
- other: Human absorption study.
- Endpoint addressed:
- basic toxicokinetics
Test guideline
- Qualifier:
- no guideline available
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Etidronic acid
- EC Number:
- 220-552-8
- EC Name:
- Etidronic acid
- Cas Number:
- 2809-21-4
- Molecular formula:
- C2H8O7P2
- IUPAC Name:
- (1-hydroxyethane-1,1-diyl)bis(phosphonic acid)
- Reference substance name:
- to follow
- IUPAC Name:
- to follow
- Details on test material:
- 14C-HEDP.
No further details.
Constituent 1
Constituent 2
Method
- Details on study design:
- A single oral dose of 0.3 mg/kg bw 14C-HEDP was administered to eight volunteers. Group A (n=5) received HEDP after breakfast, and Group B (n=3) before breakfast. Absorption was determined by measuring the activity excreted with urine and faeces.
Results and discussion
- Results:
- The activity excreted with urine was 0.082% (Group A) and 0.532% (Group B) of the applied dose.
Applicant's summary and conclusion
- Conclusions:
- In a summary of a human oral absorption study (reliability score 4) a single oral dose of 0.3 mg/kg bw 14C-HEDP was administered to eight volunteers. Group A (n=5) received HEDP after breakfast, and Group B (n=3) before breakfast. Absorption was determined by measuring the activity excreted with urine and faeces. The activity excreted with urine was 0.082% (Group A) and 0.532% (Group B) of the applied dose.
- Executive summary:
In a summary of a human oral absorption study (reliability score 4) a single oral dose of 0.3 mg/kg bw 14C-HEDP was administered to eight volunteers. Group A (n=5) received HEDP after breakfast, and Group B (n=3) before breakfast. Absorption was determined by measuring the activity excreted with urine and faeces. The activity excreted with urine was 0.082% (Group A) and 0.532% (Group B) of the applied dose. This result was comparable that of a similar study in rats (see Section 7.1.1.).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
